OurInsightsTitle

Our extensive experience in health technology
assessment (HTA) through providing strategic
advice and guiding evidence generation to
support submissions to UK HTA bodies, enables
us to provide you with a tailored solution to
reimbursement and patient access.

Stephen Kay, Amanda Strickson, Jorge Puelles, Ross Selby, Eugene Benson & Keith Tolley. Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Diabetes Ther (2017) 8:251–273.​

Register to access the Tolley insights